No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population

Neuroscience Letters

Volumn 395, Issue 2, 2006, Pages 175-178

  Lee, Kyu Young ^a   Ahn, Yong Min ^a,b   Joo, Eun Jeong ^c   Jeong, Seong Hoon ^d   Chang, Jae Seung ^a   Kim, Seong Chan ^a   Kim, Yong Sik ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Eulji University   (South Korea)

^d Dongguk University   (South Korea)

Author keywords

Bipolar disorder; Glycogen synthase kinase 3 beta; Polymorphisms; Schizophrenia

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; KOREA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIPOLAR DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 31944448355     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.10.059     Document Type: Article

References (21)

1. H. Alimohamad, N. Rajakumar, Y.H. Seah, and W. Rushlow Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum Biol. Psychiatry 57 2005 533 542
2. S. Amar, B.C. Jones, C. Nadri, N. Kozlovsky, R.H. Belmaker, and G. Agam Genetic correlational analysis of glycogen synthase kinase-3 beta and prepulse inhibition in inbred mice Genes Brain Behav. 3 2004 178 180
3. R.F. Badenhop, M.J. Moses, A. Scimone, P.B. Mitchell, K.R. Ewen-White, A. Rosso, J.A. Donald, L.J. Adams, and P.R. Schofield A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19 Mol. Psychiatry 7 2002 851 859
4. U. Bailer, F. Leisch, K. Meszaros, E. Lenzinger, U. Willinger, R. Strobl, A. Heiden, C. Gebhardt, E. Doge, K. Fuchs, W. Sieghart, S. Kasper, K. Hornik, and H.N. Aschauer Genome scan for susceptibility loci for schizophrenia and bipolar disorder Biol. Psychiatry 52 2002 40 52
5. C. Beasley, D. Cotter, and I. Everall An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder Schizophr. Res. 58 2002 63 67
6. F. Benedetti, A. Bernasconi, C. Lorenzi, A. Pontiggia, A. Serretti, C. Colombo, and E. Smeraldi A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder Neurosci. Lett. 355 2004 37 40
7. F. Benedetti, A. Serretti, C. Colombo, C. Lorenzi, V. Tubazio, and E. Smeraldi A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression Neurosci. Lett. 368 2004 123 126
8. F. Benedetti, A. Serretti, A. Pontiggia, A. Bernasconi, C. Lorenzi, C. Colombo, and E. Smeraldi Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50 T/C SNP Neurosci. Lett. 376 2005 51 55
9. N. Craddock, M.C. O'Donovan, and M.J. Owen The genetics of schizophrenia and bipolar disorder: dissecting psychosis J. Med. Genet. 42 2005 193 204
10. E.S. Emamian, D. Hall, M.J. Birnbaum, M. Karayiorgou, and J.A. Gogos Convergent evidence for impaired AKT1-GSK-3 beta signaling in schizophrenia Nat. Genet. 36 2004 131 137
11. T.D. Gould, and H.K. Manji Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs Neuropsychopharmacology 30 2005 1223 1237
12. M. Ikeda, N. Iwata, T. Suzuki, T. Kitajima, Y. Yamanouchi, Y. Kinoshita, and N. Ozaki No association of GSK-3 beta gene (GSK-3 B) with Japanese schizophrenia Am. J. Med. Genet. B Neuropsychiatr. Genet. 134 2005 90 92
13. E.J. Joo, Y.H. Joo, J.P. Hong, S. Hwang, S.J. Maeng, J.H. Han, B.H. Yang, Y.S. Lee, and Y.S. Kim Korean version of the diagnostic interview for genetic studies: validity and reliability Compr. Psychiatry 45 2004 225 229
14. U.G. Kang, M.S. Seo, M.S. Roh, Y. Kim, S.C. Yoon, and Y.S. Kim The effects of clozapine on the GSK-3-mediated signaling pathway FEBS Lett. 560 2004 115 119
15. A.J. Kim, Y. Shi, R.C. Austin, and G.H. Werstuck Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3 J. Cell. Sci. 118 2005 89 99
16. N. Kozlovsky, C. Nadri, and G. Agam Low GSK-3 in schizophrenia as a consequence of neurodevelopmental Eur. Neuropsychopharmacol. 15 2005 1 11
17. J.I. Nurnberger, M.C. Blehar, C.A. Kaufmann, C. York-Cooler, S.G. Simpson, J. Harkavy-Friedman, J.B. Severe, D. Malaspina, and T. Reich Diagnostic interview for genetic studies. Rationale, unique features, and training NIMH genetics initiative Arch. Gen. Psychiatry 51 1994 849 859
18. M.S. Roh, U.G. Kang, S.Y. Shin, Y.H. Lee, H.Y. Jung, Y.S. Juhnn, and Y.S. Kim Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3 beta after electroconvulsive shock in the rat brain Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 1 5
19. C. Russ, S. Lovestone, and J.F. Powell Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease Mol. Psychiatry 6 2001 320 324
20. C. Scassellati, C. Bonvicini, J. Perez, L. Bocchio-Chiavetto, G.B. Tura, G. Rossi, G. Racagni, and M. Gennarelli Association study of -1727 A/T, -50 C/T, and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia Neuropsychobiology 50 2004 16 20
21. P.C. Shaw, A.F. Davies, K.F. Lau, M. Garcia-Barcelo, M.M. Waye, S. Lovestone, C.C. Miller, and B.H. Anderton Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes Genome 41 1998 720 727